Report Detail
Global Implantable Cardioverter-Defibrillators (ICD) Market Report 2018-2029
- RnM3088428 |
- 22 August, 2023 |
- Global |
- 149 Pages |
- HJResearch |
- Other
Implantable Cardioverter-Defibrillators (ICD) are medical devices that are used to treat patients with heart rhythm disorders. These devices are implanted under the skin of the chest and are designed to monitor the heart's rhythm and deliver an electrical shock if an abnormal rhythm is detected. The purpose of an ICD is to prevent sudden cardiac death in patients with certain types of heart disease.
The use of ICDs has become increasingly common in recent years, as they offer an effective treatment option for patients with heart rhythm disorders. ICDs are mainly used in ambulatory surgical centers, hospitals, and clinics.
According to this market research, the global ICD market is expected to reach US$6,684.4 million in size in 2022, with a compound annual growth rate (CAGR) of 3.34%. This growth is being driven by factors such as the increasing prevalence of heart diseases, advancements in technology, and the growing demand for effective treatment options.
In terms of industry status, the ICD market is highly competitive, with several established players and new entrants vying for market share. Major global manufacturers of ICDs include ZOLL Medical Corporation (US), Boston Scientific Corporation (US), BIOTRONIK SE & Co. KG (Germany), Medtronic PLC (Ireland), St. Jude Medical, Inc. (US), Koninklijke Philips N.V. (Netherlands), Sorin Group, Nihon Kohden Corporation, and PHILIPS HEALTHCARE.
The largest end-users of ICDs are hospitals and clinics, which account for the majority of the market share. However, there is also a growing demand for ICDs in ambulatory surgical centers.
Looking ahead, the prospects for the ICD industry are positive, with continued technological advancements driving growth and innovation in the field. The trend of personalized medicine is also expected to provide opportunities for the development of targeted therapies based on individual patient characteristics.
In conclusion, the ICD industry is an important and growing segment of the medical equipment market. The use of ICDs is increasingly essential in modern medicine, and the industry is expected to continue its growth trajectory in the coming years. With established players and new entrants competing for market share, there are opportunities for innovative products and services that meet the needs of patients and healthcare providers alike.
The SWOT analysis of the Implantable Cardioverter-Defibrillators (ICD) industry is as follows:
Strengths:
Highly effective treatment option for patients with heart rhythm disorders.
Increasing prevalence of heart diseases is driving demand for ICDs.
Technological advancements are improving the efficacy and usability of ICDs.
Established players have strong brand recognition and established distribution networks.
Weaknesses:
High cost of ICDs can limit accessibility for some patients.
The implantation procedure is invasive and carries risks.
Potential for device malfunctions or failures creates safety concerns.
Lack of awareness and education among patients and healthcare providers can limit adoption.
Opportunities:
Growing demand for effective treatment options, particularly in emerging markets.
Advances in personalized medicine present opportunities for targeted therapies using ICDs.
Increasing focus on remote patient monitoring and telehealth can improve access and patient outcomes.
Potential for partnerships and collaborations between established manufacturers and startups to drive innovation.
Threats:
Regulatory requirements can create barriers to market entry for new competitors.
Competition from alternative treatment options such as medication or surgical interventions.
Economic downturns can impact demand for elective medical procedures such as ICD implantation.
Reimbursement policies and changes in healthcare legislation can impact pricing and market demand.
Key players in global Implantable Cardioverter-Defibrillators (ICD) market include:
ZOLL Medical Corporation (US)
Boston Scientific Corporation (US)
BIOTRONIK SE & Co. KG (Germany)
Medtronic PLC (Ireland)
St. Jude Medical, Inc. (US)
Koninklijke Philips N.V. (Netherlands)
Medtronic Plc
PHILIPS HEALTHCARE
Sorin Group
Nihon Kohden Corporation
Market segmentation, by product types:
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Market segmentation, by applications:
ASCs
Hospital
Clinic
1 Industry Overview of Implantable Cardioverter-Defibrillators (ICD)
- 1.1 Research Scope
- 1.2 Market Segmentation by Types of Implantable Cardioverter-Defibrillators (ICD)
- 1.3 Market Segmentation by End Users of Implantable Cardioverter-Defibrillators (ICD)
- 1.4 Market Dynamics Analysis of Implantable Cardioverter-Defibrillators (ICD)
- 1.4.1 Market Drivers
- 1.4.2 Market Challenges
- 1.4.3 Market Opportunities
- 1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Implantable Cardioverter-Defibrillators (ICD) Industry
- 2.1 ZOLL Medical Corporation (US)
- 2.1.1 Company Overview
- 2.1.2 Main Products and Specifications
- 2.1.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.1.4 Contact Information
- 2.2 Boston Scientific Corporation (US)
- 2.2.1 Company Overview
- 2.2.2 Main Products and Specifications
- 2.2.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.2.4 Contact Information
- 2.3 BIOTRONIK SE & Co. KG (Germany)
- 2.3.1 Company Overview
- 2.3.2 Main Products and Specifications
- 2.3.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.3.4 Contact Information
- 2.4 Medtronic PLC (Ireland)
- 2.4.1 Company Overview
- 2.4.2 Main Products and Specifications
- 2.4.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.4.4 Contact Information
- 2.5 St. Jude Medical, Inc. (US)
- 2.5.1 Company Overview
- 2.5.2 Main Products and Specifications
- 2.5.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.5.4 Contact Information
- 2.6 Koninklijke Philips N.V. (Netherlands)
- 2.6.1 Company Overview
- 2.6.2 Main Products and Specifications
- 2.6.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.6.4 Contact Information
- 2.7 Medtronic Plc
- 2.7.1 Company Overview
- 2.7.2 Main Products and Specifications
- 2.7.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.7.4 Contact Information
- 2.8 PHILIPS HEALTHCARE
- 2.8.1 Company Overview
- 2.8.2 Main Products and Specifications
- 2.8.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.8.4 Contact Information
- 2.9 Sorin Group
- 2.9.1 Company Overview
- 2.9.2 Main Products and Specifications
- 2.9.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.9.4 Contact Information
- 2.10 Nihon Kohden Corporation
- 2.10.1 Company Overview
- 2.10.2 Main Products and Specifications
- 2.10.3 Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.10.4 Contact Information
3 Global Implantable Cardioverter-Defibrillators (ICD) Market Analysis by Regions, Manufacturers, Types and End Users
- 3.1 Global Sales Volume and Revenue of Implantable Cardioverter-Defibrillators (ICD) by Regions (2018-2023)
- 3.2 Global Sales Volume and Revenue of Implantable Cardioverter-Defibrillators (ICD) by Manufacturers (2018-2023)
- 3.3 Global Sales Volume and Revenue of Implantable Cardioverter-Defibrillators (ICD) by Types (2018-2023)
- 3.4 Global Sales Volume and Revenue of Implantable Cardioverter-Defibrillators (ICD) by End Users (2018-2023)
- 3.5 Selling Price Analysis of Implantable Cardioverter-Defibrillators (ICD) by Regions, Manufacturers, Types and End Users in (2018-2023)
4 Northern America Implantable Cardioverter-Defibrillators (ICD) Market Analysis by Countries, Types and End Users
- 4.1 Northern America Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 4.2 Northern America Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Types (2018-2023)
- 4.3 Northern America Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 4.4 United States Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 4.5 Canada Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5 Europe Implantable Cardioverter-Defibrillators (ICD) Market Analysis by Countries, Types and End Users
- 5.1 Europe Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 5.2 Europe Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Types (2018-2023)
- 5.3 Europe Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 5.4 Germany Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.5 France Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.6 UK Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.7 Italy Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.8 Russia Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.9 Spain Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.10 Netherlands Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Market Analysis by Countries, Types and End Users
- 6.1 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 6.2 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Types (2018-2023)
- 6.3 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 6.4 China Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.5 Japan Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.6 Korea Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.7 India Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.8 Australia Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.9 Indonesia Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.10 Vietnam Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7 Latin America Implantable Cardioverter-Defibrillators (ICD) Market Analysis by Countries, Types and End Users
- 7.1 Latin America Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 7.2 Latin America Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Types (2018-2023)
- 7.3 Latin America Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 7.4 Brazil Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.5 Mexico Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.6 Argentina Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.7 Colombia Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8 Middle East & Africa Implantable Cardioverter-Defibrillators (ICD) Market Analysis by Countries, Types and End Users
- 8.1 Middle East & Africa Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 8.2 Middle East & Africa Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by Types (2018-2023)
- 8.3 Middle East & Africa Implantable Cardioverter-Defibrillators (ICD) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 8.4 Turkey Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.5 Saudi Arabia Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.6 South Africa Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.7 Egypt Implantable Cardioverter-Defibrillators (ICD) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
- 9.1 Marketing Channel
- 9.1.1 Direct Channel
- 9.1.2 Indirect Channel
- 9.2 Distributors and Traders
10 Global Implantable Cardioverter-Defibrillators (ICD) Market Forecast by Regions, Countries, Manufacturers, Types and End Users
- 10.1 Global Sales Volume and Revenue Forecast of Implantable Cardioverter-Defibrillators (ICD) by Regions (2024-2029)
- 10.2 Global Sales Volume and Revenue Forecast of Implantable Cardioverter-Defibrillators (ICD) by Types (2024-2029)
- 10.3 Global Sales Volume and Revenue Forecast of Implantable Cardioverter-Defibrillators (ICD) by End Users (2024-2029)
- 10.4 Global Revenue Forecast of Implantable Cardioverter-Defibrillators (ICD) by Countries (2024-2029)
- 10.4.1 United States Revenue Forecast (2024-2029)
- 10.4.2 Canada Revenue Forecast (2024-2029)
- 10.4.3 Germany Revenue Forecast (2024-2029)
- 10.4.4 France Revenue Forecast (2024-2029)
- 10.4.5 UK Revenue Forecast (2024-2029)
- 10.4.6 Italy Revenue Forecast (2024-2029)
- 10.4.7 Russia Revenue Forecast (2024-2029)
- 10.4.8 Spain Revenue Forecast (2024-2029)
- 10.4.9 Netherlands Revenue Forecast (2024-2029)
- 10.4.10 China Revenue Forecast (2024-2029)
- 10.4.11 Japan Revenue Forecast (2024-2029)
- 10.4.12 Korea Revenue Forecast (2024-2029)
- 10.4.13 India Revenue Forecast (2024-2029)
- 10.4.14 Australia Revenue Forecast (2024-2029)
- 10.4.15 Indonesia Revenue Forecast (2024-2029)
- 10.4.16 Vietnam Revenue Forecast (2024-2029)
- 10.4.17 Brazil Revenue Forecast (2024-2029)
- 10.4.18 Mexico Revenue Forecast (2024-2029)
- 10.4.19 Argentina Revenue Forecast (2024-2029)
- 10.4.20 Colombia Revenue Forecast (2024-2029)
- 10.4.21 Turkey Revenue Forecast (2024-2029)
- 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
- 10.4.23 South Africa Revenue Forecast (2024-2029)
- 10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Implantable Cardioverter-Defibrillators (ICD)
- 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Implantable Cardioverter-Defibrillators (ICD)
- 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Implantable Cardioverter-Defibrillators (ICD)
- 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Implantable Cardioverter-Defibrillators (ICD)
- 11.2 Downstream Major Consumers Analysis of Implantable Cardioverter-Defibrillators (ICD)
- 11.3 Major Suppliers of Implantable Cardioverter-Defibrillators (ICD) with Contact Information
- 11.4 Supply Chain Relationship Analysis of Implantable Cardioverter-Defibrillators (ICD)
12 Implantable Cardioverter-Defibrillators (ICD) New Project Investment Feasibility Analysis
- 12.1 Implantable Cardioverter-Defibrillators (ICD) New Project SWOT Analysis
- 12.2 Implantable Cardioverter-Defibrillators (ICD) New Project Investment Feasibility Analysis
- 12.2.1 Project Name
- 12.2.2 Investment Budget
- 12.2.3 Project Product Solutions
- 12.2.4 Project Schedule
13 Implantable Cardioverter-Defibrillators (ICD) Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.2 References and Data Sources
- 14.2.1 Primary Sources
- 14.2.2 Secondary Paid Sources
- 14.2.3 Secondary Public Sources
- 14.3 Abbreviations and Units of Measurement
- 14.4 Author Details
Summary:
Get latest Market Research Reports on Implantable Cardioverter-Defibrillators (ICD). Industry analysis & Market Report on Implantable Cardioverter-Defibrillators (ICD) is a syndicated market report, published as Global Implantable Cardioverter-Defibrillators (ICD) Market Report 2018-2029. It is complete Research Study and Industry Analysis of Implantable Cardioverter-Defibrillators (ICD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
